Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Arbonés ML[au]:

DYRK1A and cognition: A lifelong relationship. Arbones ML et al. Pharmacol Ther. (2019)

DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. Luna J et al. Gut. (2019)

DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells. Rozen EJ et al. Cell Rep. (2018)

Search results

Items: 1 to 50 of 51

1.

Automated Macro Approach to Quantify Synapse Density in 2D Confocal Images from Fixed Immunolabeled Neural Tissue Sections.

Rebollo E, Boix-Fabrés J, Arbones ML.

Methods Mol Biol. 2019;2040:71-97. doi: 10.1007/978-1-4939-9686-5_5.

PMID:
31432476
2.

Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.

Arranz J, Balducci E, Arató K, Sánchez-Elexpuru G, Najas S, Parras A, Rebollo E, Pijuan I, Erb I, Verde G, Sahun I, Barallobre MJ, Lucas JJ, Sánchez MP, de la Luna S, Arbonés ML.

Neurobiol Dis. 2019 Jul;127:210-222. doi: 10.1016/j.nbd.2019.02.022. Epub 2019 Mar 1.

3.

DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.

Luna J, Boni J, Cuatrecasas M, Bofill-De Ros X, Núñez-Manchón E, Gironella M, Vaquero EC, Arbones ML, de la Luna S, Fillat C.

Gut. 2019 Aug;68(8):1465-1476. doi: 10.1136/gutjnl-2018-316128. Epub 2018 Oct 20.

PMID:
30343272
4.

DYRK1A and cognition: A lifelong relationship.

Arbones ML, Thomazeau A, Nakano-Kobayashi A, Hagiwara M, Delabar JM.

Pharmacol Ther. 2019 Feb;194:199-221. doi: 10.1016/j.pharmthera.2018.09.010. Epub 2018 Sep 28. Review.

PMID:
30268771
5.

DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells.

Rozen EJ, Roewenstrunk J, Barallobre MJ, Di Vona C, Jung C, Figueiredo AF, Luna J, Fillat C, Arbonés ML, Graupera M, Valverde MA, de la Luna S.

Cell Rep. 2018 May 8;23(6):1867-1878. doi: 10.1016/j.celrep.2018.04.008.

6.

DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.

Najas S, Arranz J, Lochhead PA, Ashford AL, Oxley D, Delabar JM, Cook SJ, Barallobre MJ, Arbonés ML.

EBioMedicine. 2015 Jan 17;2(2):120-34. doi: 10.1016/j.ebiom.2015.01.010. eCollection 2015.

7.

Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.

Blazek JD, Malik AM, Tischbein M, Arbones ML, Moore CS, Roper RJ.

Mech Dev. 2015 May;136:133-42. doi: 10.1016/j.mod.2014.12.004. Epub 2014 Dec 30.

8.

Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.

García-Cerro S, Martínez P, Vidal V, Corrales A, Flórez J, Vidal R, Rueda N, Arbonés ML, Martínez-Cué C.

PLoS One. 2014 Sep 4;9(9):e106572. doi: 10.1371/journal.pone.0106572. eCollection 2014.

9.

Plasma DYRK1A as a novel risk factor for Alzheimer's disease.

Janel N, Sarazin M, Corlier F, Corne H, de Souza LC, Hamelin L, Aka A, Lagarde J, Blehaut H, Hindié V, Rain JC, Arbones ML, Dubois B, Potier MC, Bottlaender M, Delabar JM.

Transl Psychiatry. 2014 Aug 12;4:e425. doi: 10.1038/tp.2014.61.

10.

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.

Barallobre MJ, Perier C, Bové J, Laguna A, Delabar JM, Vila M, Arbonés ML.

Cell Death Dis. 2014 Jun 12;5:e1289. doi: 10.1038/cddis.2014.253.

11.

Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass.

Rachdi L, Kariyawasam D, Guez F, Aïello V, Arbonés ML, Janel N, Delabar JM, Polak M, Scharfmann R.

Diabetologia. 2014 May;57(5):960-9. doi: 10.1007/s00125-014-3174-3. Epub 2014 Jan 30.

PMID:
24477974
12.

Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.

Martin KR, Layton D, Seach N, Corlett A, Barallobre MJ, Arbonés ML, Boyd RL, Scott B, Pritchard MA.

J Med Genet. 2013 Jul;50(7):444-54. doi: 10.1136/jmedgenet-2013-101522. Epub 2013 May 3.

PMID:
23644448
13.

Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome.

Laguna A, Barallobre MJ, Marchena MÁ, Mateus C, Ramírez E, Martínez-Cue C, Delabar JM, Castelo-Branco M, de la Villa P, Arbonés ML.

Hum Mol Genet. 2013 Jul 15;22(14):2775-84. doi: 10.1093/hmg/ddt125. Epub 2013 Mar 19.

PMID:
23512985
14.

Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.

Martin KR, Corlett A, Dubach D, Mustafa T, Coleman HA, Parkington HC, Merson TD, Bourne JA, Porta S, Arbonés ML, Finkelstein DI, Pritchard MA.

Hum Mol Genet. 2012 Jul 1;21(13):3025-41. doi: 10.1093/hmg/dds134. Epub 2012 Apr 17.

PMID:
22511596
15.

Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.

Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E.

J Neuroinflammation. 2012 Mar 7;9:48. doi: 10.1186/1742-2094-9-48.

16.

Regulator of calcineurin 1 mediates pathological vascular wall remodeling.

Esteban V, Méndez-Barbero N, Jiménez-Borreguero LJ, Roqué M, Novensá L, García-Redondo AB, Salaices M, Vila L, Arbonés ML, Campanero MR, Redondo JM.

J Exp Med. 2011 Sep 26;208(10):2125-39. doi: 10.1084/jem.20110503. Epub 2011 Sep 19.

17.

Gene expression analysis of the embryonic subplate.

Oeschger FM, Wang WZ, Lee S, García-Moreno F, Goffinet AM, Arbonés ML, Rakic S, Molnár Z.

Cereb Cortex. 2012 Jun;22(6):1343-59. doi: 10.1093/cercor/bhr197. Epub 2011 Aug 22.

18.

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ.

Nat Cell Biol. 2010 Dec;12(12):1220-7. doi: 10.1038/ncb2126. Epub 2010 Nov 21.

PMID:
21102440
19.

Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling.

Ferron SR, Pozo N, Laguna A, Aranda S, Porlan E, Moreno M, Fillat C, de la Luna S, Sánchez P, Arbonés ML, Fariñas I.

Cell Stem Cell. 2010 Sep 3;7(3):367-79. doi: 10.1016/j.stem.2010.06.021.

20.

Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice.

Arqué G, de Lagrán MM, Arbonés ML, Dierssen M.

Neurobiol Dis. 2009 Nov;36(2):312-9. doi: 10.1016/j.nbd.2009.07.027. Epub 2009 Aug 4.

PMID:
19660545
21.

The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development.

Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fernández E, Fotaki V, Delabar JM, de la Luna S, de la Villa P, Arbonés ML.

Dev Cell. 2008 Dec;15(6):841-53. doi: 10.1016/j.devcel.2008.10.014.

22.

Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A).

Arqué G, Fotaki V, Fernández D, Martínez de Lagrán M, Arbonés ML, Dierssen M.

PLoS One. 2008 Jul 2;3(7):e2575. doi: 10.1371/journal.pone.0002575.

23.

Efficient and specific transduction of cochlear supporting cells by adeno-associated virus serotype 5.

Ballana E, Wang J, Venail F, Estivill X, Puel JL, Arbonès ML, Bosch A.

Neurosci Lett. 2008 Sep 12;442(2):134-9. doi: 10.1016/j.neulet.2008.06.060. Epub 2008 Jun 26.

PMID:
18601973
24.

DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.

Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, Zhao YF, Chen C, Porta S, Arbonés ML, Mittaz L, Pritchard MA.

Hum Mol Genet. 2008 Apr 1;17(7):1020-30. doi: 10.1093/hmg/ddm374. Epub 2008 Jan 7.

PMID:
18180251
25.
26.

RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration.

Porta S, Serra SA, Huch M, Valverde MA, Llorens F, Estivill X, Arbonés ML, Martí E.

Hum Mol Genet. 2007 May 1;16(9):1039-50. Epub 2007 Mar 6.

PMID:
17341486
27.

Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-).

Martinez de Lagran M, Bortolozzi A, Millan O, Gispert JD, Gonzalez JR, Arbones ML, Artigas F, Dierssen M.

Genes Brain Behav. 2007 Aug;6(6):569-78. Epub 2006 Nov 28.

28.

Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse.

Benavides-Piccione R, Dierssen M, Ballesteros-Yáñez I, Martínez de Lagrán M, Arbonés ML, Fotaki V, DeFelipe J, Elston GN.

Neurobiol Dis. 2005 Oct;20(1):115-22.

PMID:
16137572
29.

Expression profiles of the connexin genes, Gjb1 and Gjb3, in the developing mouse cochlea.

López-Bigas N, Arbonés ML, Estivill X, Simonneau L.

Mech Dev. 2002 Dec;119 Suppl 1:S111-5.

30.

Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis.

Feliubadaló L, Arbonés ML, Mañas S, Chillarón J, Visa J, Rodés M, Rousaud F, Zorzano A, Palacín M, Nunes V.

Hum Mol Genet. 2003 Sep 1;12(17):2097-108. Epub 2003 Jul 15.

PMID:
12915471
31.

Expression profiles of the connexin genes, Gjb1 and Gjb3, in the developing mouse cochlea.

López-Bigas N, Arbonés ML, Estivill X, Simonneau L.

Gene Expr Patterns. 2002 Nov;2(1-2):113-7.

PMID:
12617848
32.

Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Fotaki V, Dierssen M, Alcántara S, Martínez S, Martí E, Casas C, Visa J, Soriano E, Estivill X, Arbonés ML.

Mol Cell Biol. 2002 Sep;22(18):6636-47.

33.

Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression.

Thönnissen E, Rabionet R, Arbonès ML, Estivill X, Willecke K, Ott T.

Hum Genet. 2002 Aug;111(2):190-7. Epub 2002 Jun 22.

PMID:
12189493
34.

Erratum: Identification of five new mutations of PDS/SLC26A4 in Mediterranean families with hearing impairment.

López-Bigas N, Melchionda S, de Cid R, Grifa A, Zelante L, Govea N, Arbonés ML, Gasparini P, Estivill X.

Hum Mutat. 2002 Jul;20(1):77-8.

PMID:
12112665
35.

Connexin mutations in hearing loss, dermatological and neurological disorders.

Rabionet R, López-Bigas N, Arbonès ML, Estivill X.

Trends Mol Med. 2002 May;8(5):205-12. Review.

PMID:
12067629
36.

A common frameshift mutation and other variants in GJB4 (connexin 30.3): Analysis of hearing impairment families.

López-Bigas N, Melchionda S, Gasparini P, Borragán A, Arbonés ML, Estivill X.

Hum Mutat. 2002 Apr;19(4):458.

PMID:
11933201
37.

Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients.

Wattenhofer M, Di Iorio MV, Rabionet R, Dougherty L, Pampanos A, Schwede T, Montserrat-Sentis B, Arbones ML, Iliades T, Pasquadibisceglie A, D'Amelio M, Alwan S, Rossier C, Dahl HH, Petersen MB, Estivill X, Gasparini P, Scott HS, Antonarakis SE.

J Mol Med (Berl). 2002 Feb;80(2):124-31. Epub 2001 Dec 18.

PMID:
11907649
38.

Functional genomics of Down syndrome: a multidisciplinary approach.

Dierssen M, Martí E, Pucharcós C, Fotaki V, Altafaj X, Casas K, Solans A, Arbonés ML, Fillat C, Estivill X.

J Neural Transm Suppl. 2001;(61):131-48. Review.

PMID:
11771739
39.

Identification of five new mutations of PDS/SLC26A4 in Mediterranean families with hearing impairment.

López-Bigas N, Melchionda S, de Cid R, Grifa A, Zelante L, Govea N, Arbonés ML, Gasparini P, Estivill X.

Hum Mutat. 2001 Dec;18(6):548. Corrected and republished in: Hum Mutat. 2002 Jul;20(1):77-8.

PMID:
11748854
40.

MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss.

Melchionda S, Ahituv N, Bisceglia L, Sobe T, Glaser F, Rabionet R, Arbones ML, Notarangelo A, Di Iorio E, Carella M, Zelante L, Estivill X, Avraham KB, Gasparini P.

Am J Hum Genet. 2001 Sep;69(3):635-40. Epub 2001 Jul 20.

41.

Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment.

López-Bigas N, Olivé M, Rabionet R, Ben-David O, Martínez-Matos JA, Bravo O, Banchs I, Volpini V, Gasparini P, Avraham KB, Ferrer I, Arbonés ML, Estivill X.

Hum Mol Genet. 2001 Apr 15;10(9):947-52.

PMID:
11309368
42.

R32W variant in Connexin 31: mutation or polymorphism for deafness and skin disease?

López-Bigas N, Rabionet R, Arbonés ML, Estivill X.

Eur J Hum Genet. 2001 Jan;9(1):70. No abstract available.

43.

Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene.

Rabionet R, Zelante L, López-Bigas N, D'Agruma L, Melchionda S, Restagno G, Arbonés ML, Gasparini P, Estivill X.

Hum Genet. 2000 Jan;106(1):40-4.

PMID:
10982180
44.

Identification of seven novel SNPS (five nucleotide and two amino acid substitutions) in the connexin31 (GJB3) gene.

López-Bigas N, Rabionet R, Martínez E, Banchs I, Volpini V, Vance JM, Arbonés ML, Estivill X.

Hum Mutat. 2000 May;15(5):481-2.

PMID:
10790215
45.

Mutations in the mitochondrial tRNA Ser(UCN) and in the GJB2 (connexin 26) gene are not modifiers of the age at onset or severity of hearing loss in Spanish patients with the 12S rRNA A1555G mutation.

López-Bigas N, Rabionet R, Martinez E, Bravo O, Girons J, Borragan A, Pellicer M, Arbonés ML, Estivill X.

Am J Hum Genet. 2000 Apr;66(4):1465-7. No abstract available.

46.

Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.

López-Bigas N, Rabionet R, de Cid R, Govea N, Gasparini P, Zelante L, Arbonés ML, Estivill X.

Hum Mutat. 1999;14(6):520-6.

PMID:
10571950
47.

Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome.

Pucharcós C, Fuentes JJ, Casas C, de la Luna S, Alcántara S, Arbonés ML, Soriano E, Estivill X, Pritchard M.

Eur J Hum Genet. 1999 Sep;7(6):704-12.

48.

Characteristics of nitric oxide synthase type I of rat cerebellar astrocytes.

Arbonés ML, Ribera J, Agulló L, Baltrons MA, Casanovas A, Riveros-Moreno V, García A.

Glia. 1996 Nov;18(3):224-32.

PMID:
8915654
49.

Sequential contribution of L- and P-selectin to leukocyte rolling in vivo.

Ley K, Bullard DC, Arbonés ML, Bosse R, Vestweber D, Tedder TF, Beaudet AL.

J Exp Med. 1995 Feb 1;181(2):669-75.

50.

Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice.

Arbonés ML, Ord DC, Ley K, Ratech H, Maynard-Curry C, Otten G, Capon DJ, Tedder TF.

Immunity. 1994 Jul;1(4):247-60.

PMID:
7534203

Supplemental Content

Loading ...
Support Center